e.g. mhealth
Search Results (1 to 10 of 633 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 177 JMIR Cancer
- 132 Journal of Medical Internet Research
- 112 JMIR Research Protocols
- 59 JMIR Formative Research
- 28 JMIR mHealth and uHealth
- 24 JMIR Dermatology
- 19 JMIR Public Health and Surveillance
- 18 JMIR Medical Informatics
- 13 JMIRx Med
- 6 JMIR Human Factors
- 6 JMIR Infodemiology
- 5 JMIR AI
- 5 JMIR Pediatrics and Parenting
- 5 JMIR Serious Games
- 4 Interactive Journal of Medical Research
- 4 Iproceedings
- 3 Journal of Participatory Medicine
- 2 JMIR Aging
- 2 JMIR Bioinformatics and Biotechnology
- 2 JMIR Medical Education
- 2 JMIR Mental Health
- 2 JMIR Perioperative Medicine
- 1 JMIR Biomedical Engineering
- 1 JMIR Cardio
- 1 JMIRx Bio
- 0 Medicine 2.0
- 0 iProceedings
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Data
- 0 JMIR Nursing
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)

Risk prediction models for cancer could improve early detection rates. These models combine patient data, such as patient demographics, medical history, or cancer symptoms, to identify patients with an increased risk of undiagnosed cancer.
Blood tests commonly performed in clinical practice, including full blood count (FBC) and liver function tests, are often included in cancer risk prediction models, as they have an important role in risk-stratifying symptomatic patients for cancer investigation [10,11].
JMIR Cancer 2025;11:e70275
Download Citation: END BibTex RIS

Since 2018, Dutch pediatric cancer care has been centralized at the Princess Máxima Center, optimizing treatment outcomes and reducing toxicity [22]. Building on this model, the national Cancer in Pregnancy (CIP) offspring outpatient clinic was allowed to be hosted in this center to monitor all Dutch children prenatally exposed to maternal cancer and its treatment.
JMIR Res Protoc 2025;14:e71612
Download Citation: END BibTex RIS

Cancer remains the second leading cause of death globally, with continually rising incidence rates each year [4]. Advances in cancer treatment and early detection have contributed to prolonged survival, even for patients in advanced stages. Nevertheless, extended survival often results in protracted suffering, posing significant physical, emotional, social, and spiritual challenges for both patients and their families, especially during the end-of-life phase [5].
JMIR Cancer 2025;11:e71596
Download Citation: END BibTex RIS

Case 2: Josh
A 56-year-old Black man named Josh previously had colorectal cancer. His sister participated in In Our DNA SC based on a recommendation from her doctor. Josh’s sister convinced him that it would be beneficial for him to participate. He reluctantly agreed to participate but did not see much of a point since he had already been treated for colorectal cancer. Josh received results showing that he was positive for the MLH1 gene, which means he has Lynch syndrome.
JMIR Cancer 2025;11:e65848
Download Citation: END BibTex RIS

Consequently, the development and widespread adoption of effective screening strategies have become paramount in the fight against cancer.
Among these strategies, genetic testing has emerged as a pivotal tool in cancer prevention and early detection [3]. By analyzing an individual’s DNA, genetic testing can identify mutations that may predispose individuals to various forms of cancer [4].
JMIR Cancer 2025;11:e67650
Download Citation: END BibTex RIS

The incidence and mortality rates of cancer are rapidly increasing globally. According to the International Agency for Research on Cancer, there were 19.29 million new cancer cases and 9.96 million cancer deaths worldwide in 2020, and the rise in cancer incidence and mortality rates has resulted in a significant disease burden on people [1]. The diagnosis and long-term treatment of cancer not only cause adversity for patients but also impose psychological stress and burdens on caregivers [2].
JMIR Cancer 2025;11:e67131
Download Citation: END BibTex RIS

However, in the past 3 years, an average of only 216 pediatric patients were diagnosed with cancer annually [5]. This suggests that the remaining 75%‐80% of patients remain undiagnosed and likely do not survive (Figure 1). One example is pediatric leukemia, the most common type of pediatric cancer in this region. Although this malignancy should represent 300‐480 cases (ie, 30%‐40% of all pediatric cancer diagnosis), only 40 cases per year have been seen over the last several years [5].
JMIR Form Res 2025;9:e59776
Download Citation: END BibTex RIS

Both versions of the Pan CAN Patient Registry were designed to assist the pancreatic cancer community in understanding the “Right Track” for any patient with pancreatic cancer: right team, right tests, right treatment, and the opportunity to share their data [6].
J Particip Med 2025;17:e65046
Download Citation: END BibTex RIS

Breast cancer is more commonly diagnosed in older populations, particularly among women aged 65 years and older in wealthier countries. In the United States, the average age of breast cancer diagnosis is 62 years, and in 2020, women aged 70 years and older accounted for 30% of all new cases of the disease [1,2]. In the European Union, women older than 65 years made up about 44% of all breast cancer cases [3].
JMIR Cancer 2025;11:e64000
Download Citation: END BibTex RIS

This clinician-confirmed cancer progression in unstructured text (ie, clinical notes) has been shown to serve as a reasonable surrogate for real-world indicators in ascertaining progression endpoints. This is also more practical for real-world studies than purely RECIST-based approaches [6].
JMIR Cancer 2025;11:e64697
Download Citation: END BibTex RIS